Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Serine/threonine-protein kinase B-raf | ||
| Ligand | BDBM50330916 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_685663 (CHEMBL1285565) | ||
| IC50 | 0.710000±n/a nM | ||
| Citation |  Wang, X; Berger, DM; Salaski, EJ; Torres, N; Dutia, M; Hanna, C; Hu, Y; Levin, JI; Powell, D; Wojciechowicz, D; Collins, K; Frommer, E; Lucas, J Indazolylpyrazolopyrimidine as highly potent B-Raf inhibitors with in vivo activity. J Med Chem53:7874-8 (2010) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Serine/threonine-protein kinase B-raf | |||
| Name: | Serine/threonine-protein kinase B-raf | ||
| Synonyms: | B-RAF | B-Raf Protein Kinase | B-Raf proto-oncogene serine/threonine-protein kinase | BRAF | BRAF1 | BRAF_HUMAN | RAFB1 | p94 | v-Raf murine sarcoma viral oncogene homolog B1 | ||
| Type: | Serine/threonine-protein kinase | ||
| Mol. Mass.: | 84446.00 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | P15056 | ||
| Residue: | 766 | ||
| Sequence: |
| ||
| BDBM50330916 | |||
| n/a | |||
| Name | BDBM50330916 | ||
| Synonyms: | (1S,4S)-2-(4-(3-(1H-indazol-4-yl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)phenyl)-5-methyl-2,5-diazabicyclo[2.2.2]octane | CHEMBL1276187 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C31H28N8 | ||
| Mol. Mass. | 512.6076 | ||
| SMILES | CN1C[C@@H]2CC[C@H]1CN2c1ccc(cc1)-c1ccnc2c(c(nn12)-c1ccncc1)-c1cccc2[nH]ncc12 |r,wD:6.6,3.9,(-6.71,3.85,;-6.7,2.31,;-8.04,1.53,;-8.03,-.01,;-7.27,1.33,;-6.47,.46,;-5.36,1.55,;-5.36,.01,;-6.69,-.77,;-6.69,-2.3,;-5.35,-3.07,;-5.34,-4.61,;-6.68,-5.39,;-8.01,-4.62,;-8.02,-3.09,;-6.67,-6.92,;-8,-7.69,;-8,-9.24,;-6.67,-10.01,;-5.33,-9.24,;-3.86,-9.72,;-2.94,-8.46,;-3.86,-7.21,;-5.33,-7.69,;-1.41,-8.46,;-.64,-9.8,;.9,-9.8,;1.68,-8.46,;.9,-7.12,;-.64,-7.13,;-3.38,-11.18,;-1.88,-11.5,;-1.4,-12.96,;-2.43,-14.11,;-3.94,-13.79,;-5.19,-14.69,;-6.42,-13.78,;-5.94,-12.32,;-4.41,-12.33,)| | ||
| Structure | 
| ||